Seno-Therapeutics Summit 2025

Schedule • Tuesday, September 16

08:30–09:15
Registration
09:15–09:25
Welcome Notes (CNR & Chairs)

Session 1

New Discoveries, Biomarkers & Clinical Trials: A Perspective from Academics

09:25–09:50
James Kirkland Talk
UCLA
09:50–10:15
Marissa Schafer Talk
Mayo Clinic
10:15–10:40
Andrea Alimonti Talk
IOR & ETH
10:40–11:05
Clemens Schmitt Talk
Charité University of Berlin
11:05–11:25
☕ Coffee Break
11:25–11:50
Daohong Zhou Talk
UT San Antonio
11:50–12:15
Frederick Beddingfield Talk
Rubedo Life Sciences

Round Table 1

Biomarkers & Clinical Trial Designs for Senotherapeutics

Round Table 12:15–12:50
Frederick BeddingfieldRubedo Life Sciences
James KirklandUCLA
Marissa SchaferMayo Clinic
Andrea AlimontiIOR & ETH
Daohong ZhouUT San Antonio
Marco Demaria—Chair—
12:50–13:50
🍽️ Lunch Break
13:50–14:15
Mike Sapieha Talk
Unity Biotechnologies
14:15–14:40
Alessandra Zatti Talk
Chiesi Pharmaceuticals

Round Table 2

Cellular Senescence & Longevity Therapeutics: Are Big Pharma ready to bet on Aging Biology as a key driver?

Round Table 14:40–15:05
Benjamin YadenEli Lilly and Company
Alessandra ZattiChiesi Pharmaceuticals
Alessandro LattuadaOtsuka Pharmaceutical Italy
Marco Quarta—Chair—

Session 2

Early Stage Companies

15:05–15:30
Jia Xie Talk
OneSkin
15:30–15:55
John Lewis Talk
Oisin Bio
15:55–16:15
☕ Coffee Break
16:15–16:40
Kevin Slawin Talk
Phoenix SENOLYTIX
16:40–17:05
Kevin Slawin Talk
Eos SENOLYTIX

Interlude

Senotherapeutics Biomarker Consortium

Announcement 17:05–17:25
Marco Quarta—Summit-Chair—
Marco Demaria—Summit-Chair—

Round Table 3

From Gene Delivery to Immune Surveillance & Decentralized Discovery – Translating Senescence Science into the Next Generation of Senotherapeutics

Round Table 17:25–18:00
Paolo BinettiVitaDAO
Kalon BostonMinicircle
Robin MansukhaniDeciduous Therapeutics
Marco Quarta—Co-Chair—
Marco Demaria—Co-Chair—
18:00–18:15
Conclusions and Final Remarks